drugset / Trial / NCT05234840

"Platelet-Rich Plasma" Epidural Injection an Emerging Strategy in Lumbar Disc Herniation

NCT05234840

RandomizedParallel-groupTriple-blindTreatment

Summary

To evaluate the efficacy of platelet-rich plasma (PRP; double-spin) in treatment of single-level lumbar herniated nucleus pulposus (HNP) in comparison to triamcinolone. RCT was conducted with 30 patients included.

Timeline

Start
2019-04-01
Primary completion
2021-05-01
Completion
2021-06-30

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Platelet Rich Plasma Other / unclassified 4 ml Other
Comparator Triamcinolone Other / unclassified 40 mg Other
Comparator Lidocaine Other / unclassified 1 %

Indications

No indication recorded.